Morten Andersen

Morten Andersen

Professor

Member of:

    ORCID: 0000-0001-7029-2860

    Publication year:
    All
    1 - 12 out of 12Page size: 100
    1. 2022
    2. Published

      Comparison of the incidence of acute pancreatitis among new users of fluoxetine, citalopram, and other selective serotonin reuptake inhibitors: A Danish register-based cohort study

      Aakjær, Mia, Kristiansen, S. B., Sessa, Maurizio, Pape, K., Dalhoff, Kim, De Bruin, M. L. & Andersen, Morten, 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 641-642

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    3. Published

      New tools for pharmacoepidemiological studies: Developing a lightweight modular analytics framework based on a nordic common data model (NCDM) and a general model of person-time-event data

      Andersen, Morten, Sharon, R., Kristiansen, S. & Aakjær, Mia, 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 300-301

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    4. Published

      Pharmacom-epi: A framework for integrating pharmacometric modeling into Pharmacoepidemiological research using real-world data

      Soeorg, H., Sverrisdottir, E., Andersen, Morten, Lund, Trine Meldgaard & Sessa, Maurizio, 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 568-569

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    5. Published

      Risk of new-onset type 2 diabetes in antidepressant users: A population-based cohort study in Denmark

      Sharon, R., Andersen, Morten & Lange, Theis, 2022, In: Pharmacoepidemiology and Drug Safety. 31, p. 115-116 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    6. Published

      Surveillance of antidepressant safety (SADS): Comparison of signal detection of serious medical events using tree-based scan statistics and repeated cohort studies

      Aakjær, Mia, Kulahci, M., De Bruin, M. L., Khan, A. R. & Andersen, Morten, 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 103-104

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    7. 2021
    8. Published

      Pharmacological and epidemiological considerations while constructing drug treatment episodes using observational data retrospectively collected: A simulation study

      Pazzagli, L., Andersen, Morten & Sessa, Maurizio, 2021, In: Pharmacoepidemiology and Drug Safety. 30, S1, p. 298-299

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    9. Published

      Risk of ventricular arrhythmia and all-cause mortality with citalopram or escitalopram versus paroxetine and sertraline among older adults in Denmark: A registry-based cohort study

      Werther, S. K., Aakjær, Mia, Pape, K. & Andersen, Morten, 2021, In: Pharmacoepidemiology and Drug Safety. 30, S1, p. 409-409

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    10. 2019
    11. Published

      Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark

      De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Andersen, Morten, Aug 2019.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    12. Published

      Incidence of direct Oral anticoagulation use for non Valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-National Drug Utilization Study

      Ibanez, L., Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Martin Merino, E., Montero, D., Leon-Munoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., Van den Ham, R. & 3 others, Souverein, P., Klungel, O. & Gardarsdottir, H., Aug 2019, p. 397-397.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    13. Published

      Risk of major bleeding associated with the use of direct oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: A European multi-country population-based cohort study

      Souverein, P. C., Van den Ham, H. A., Huerta, C., Martin Merino, E., Montero, D., Leon-Munoz, L. M., Schmiedl, S., Rottenkolber, M., Andersen, Morten, Aakjær, Mia, De Bruin, M. L., Klungel, O. H. & Gardarsdottir, H., Aug 2019, p. 553-553.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    14. Published

      Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: a meta-analysis of results from multiple population-based cohort studies using a common protocol in Europe and Canada

      van den Ham, H., Souverein, P., Klungel, O., Platt, R., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Martin Merino, E., Leon-Munoz, L., Montero, D., Andersen, Morten, Aakjær, Mia, De Bruin, M. & Gardarsdottir, H., Aug 2019, p. 410-411.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    15. Published

      Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy

      Callreus, T., Sessa, Maurizio, El-Galaly, T., Jerkeman, M. & Andersen, Morten, 2019, p. 190-190.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    ID: 169399129